Australian company to begin 1st human trial of COVID-19 vaccine

An Australian company has called out for volunteers in the country’s first human trial of a COVID-19 vaccine, expected to take place in coming weeks.

An Australian company has called out for volunteers in the country’s first human trial of a COVID-19 vaccine, expected to take place in coming weeks.
Clinical Research Company Nucleus Network revealed that it would test the effectiveness and safety of a Recombinant Spike Protein Nanoparticle vaccine, NVX-CoV2373, developed by US based biotechnology company Novavax, reports Xinhua news agency.
It would take roughly 12-18 months from now before the vaccine could be released to the public.
There was absolutely no chance that the volunteers could be infected with the disease by taking part.
The World Health Organization estimated at least 20 other COVID-19 candidate vaccines are in development around the world.